Literature DB >> 12512456

[Effects of components isolated from Astragalus membranaceus Bunge on cardiac function injured by myocardial ischemia reperfusion in rats].

J Y Zhou1, Y Fan, J L Kong, D Z Wu, Z B Hu.   

Abstract

OBJECTIVE: To investigate the effects of components isolated from Astragalus membranaceus on myocardial ischemia reperfusion injury.
METHODS: The myocardial ischemia reperfusion injury model was created by the left anterior descending coronary artery occlusion from the oracotouated rats, and the total saponins, total flavonids and astragaloside i.v. isolated from A. membranaceus on hemodynamics during acute myocardial ischemia, Na(+)-K(+)-ATPase activity, cAMP and malondialdehyede (MDA) contents in the ischemic myocardium were observed.
RESULTS: The total saponins, total flavonids and astragaloside i.v. attenuated the declines of the amplitudes of LVSP and +/- LVdp/dtmax in rat heart injured by ischemia reperfusion in vivo, and decreased Na(+)-K(+)-ATPase activity in the ischemic myocardium. Otherwise, the total saponins increased the cAMP content and the total flavonids decreased the level of MDA production in the ischemic myocardium.
CONCLUSION: The effects of different components isolated from A. membranaceus on protecting the cardiac function in the process of ischemia reperfusion may be related to the mechanism of improving energy metabolism, scavenging the oxygen free radicals and inhibiting the production of free radicals in the ischemic myocardium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12512456

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  12 in total

Review 1.  Research progress on mechanism of action of Radix Astragalus in the treatment of heart failure.

Authors:  Qing-You Yang; Ke-Ji Chen; Shu Lu; Hui-Ru Sun
Journal:  Chin J Integr Med       Date:  2012-04-02       Impact factor: 1.978

Review 2.  Progress in the research of Radix Astragali in treating chronic heart failure: effective ingredients, dose-effect relationship and adverse reaction.

Authors:  Shu Lu; Ke-ji Chen; Qing-you Yang; Hui-ru Sun
Journal:  Chin J Integr Med       Date:  2011-06-10       Impact factor: 1.978

3.  A novel antioxidant agent, astragalosides, prevents shock wave-induced renal oxidative injury in rabbits.

Authors:  Xiang Li; Dalin He; Linlin Zhang; Xinfa Cheng; Binwu Sheng; Yong Luo
Journal:  Urol Res       Date:  2006-06-17

4.  Astragalus prevents diabetic rats from developing cardiomyopathy by downregulating angiotensin II type2 receptors' expression.

Authors:  Changyun Li; Linsheng Cao; Qiutang Zeng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

5.  Effects of compound Shenhua tablet on renal tubular Na+-K+-ATPase in rats with acute ischemic reperfusion injury.

Authors:  Yue Yang; Ri-bao Wei; Xiao-yong Zheng; Qiang Qiu; Shao-yuan Cui; Zhong Yin; Suo-zhu Shi; Xiang-mei Chen
Journal:  Chin J Integr Med       Date:  2014-01-24       Impact factor: 1.978

6.  Dan-Shen-Yin protects the heart against inflammation and oxidative stress induced by acute ischemic myocardial injury in rats.

Authors:  Kui-Po Yan; Yong Guo; Zhihua Xing; Xi Huang; Shengping Dai; Min Duan; Xinhua Sun; Wei Huang; Weijun Peng
Journal:  Exp Ther Med       Date:  2011-12-05       Impact factor: 2.447

7.  Astragaloside IV inhibits oxidative stress-induced mitochondrial permeability transition pore opening by inactivating GSK-3β via nitric oxide in H9c2 cardiac cells.

Authors:  Yonggui He; Jinkun Xi; Huan Zheng; Yidong Zhang; Yuanzhe Jin; Zhelong Xu
Journal:  Oxid Med Cell Longev       Date:  2012-09-25       Impact factor: 6.543

8.  Global transcriptome analysis profiles metabolic pathways in traditional herb Astragalus membranaceus Bge. var. mongolicus (Bge.) Hsiao.

Authors:  Jing Chen; Xue-Ting Wu; Yi-Qin Xu; Yang Zhong; Yi-Xue Li; Jia-Kuan Chen; Xuan Li; Peng Nan
Journal:  BMC Genomics       Date:  2015-06-11       Impact factor: 3.969

9.  Astragaloside IV improves metabolic syndrome and endothelium dysfunction in fructose-fed rats.

Authors:  Ning Zhang; Xu-Hui Wang; Shi-Long Mao; Feng Zhao
Journal:  Molecules       Date:  2011-05-10       Impact factor: 4.411

Review 10.  Management of cardiorenal metabolic syndrome in diabetes mellitus: a phytotherapeutic perspective.

Authors:  Min Kyong Song; Neal M Davies; Basil D Roufogalis; Tom Hsun-Wei Huang
Journal:  J Diabetes Res       Date:  2014-04-13       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.